You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

Details for Patent: 8,053,427

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,053,427 protect, and when does it expire?

Patent 8,053,427 protects MIRVASO and is included in one NDA.

This patent has thirty-four patent family members in twenty-six countries.

Summary for Patent: 8,053,427

Scope and claims summary:

Title:	Brimonidine gel composition
Abstract:	Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.
Inventor(s):	Buge; Jean-Christophe (Nice, FR), Nadau-Fourcade; Karine (Villeneuve-Loubet, FR), Meunier; Cyril (Mougins, FR)
Assignee:	Galderma R&D SNC (Biot, FR)
Application Number:	13/158,987
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,053,427
Patent Claim Types: see list of patent claims	Composition; Compound; Formulation; Use;

Drugs Protected by US Patent 8,053,427

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Galderma Labs Lp	MIRVASO	brimonidine tartrate	GEL;TOPICAL	204708-001	Aug 23, 2013	AB	RX	Yes	Yes	8,053,427	⤷ Subscribe	Y			TOPICAL TREATMENT OF FACIAL ERYTHEMA OF ROSACEA	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,053,427

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	083651	⤷ Subscribe
Australia	2011317554	⤷ Subscribe
Brazil	112013009578	⤷ Subscribe
Canada	2814952	⤷ Subscribe
China	103298451	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.